Literature DB >> 29124378

Usefulness of Cross-Linked Human Acellular Dermal Matrix as an Implant for Dorsal Augmentation in Rhinoplasty.

Chae Eun Yang1, Soo Jung Kim1, Ji Hee Kim2, Ju Hee Lee2, Tai Suk Roh1, Won Jai Lee3.   

Abstract

BACKGROUND: Asian noses are relatively small and flat compared to Caucasians; therefore, rhinoplasty procedures often focus on dorsal augmentation and tip projection rather than reduction in the nasal framework. Various autologous and alloplastic implant materials have been used for dorsal augmentation. Recently, human acellular dermal matrices have been introduced as an implant material for dorsal augmentation, camouflaging autologous implants without an additional donor site. Here, we introduce a cross-linked human acellular dermal matrix as an implant material in augmentation rhinoplasty and share the clinical experiences.
METHODS: Eighteen patients who underwent augmentation rhinoplasty using acellular dermal matrix from April 2014 to November 2015 were reviewed retrospectively. Clinical outcomes and complications were assessed at the outpatient clinic during the follow-up period ranging from 8 to 38 months. Contour changes were assessed through comparison of preoperative and postoperative photographs by two independent plastic surgeons. Patient satisfaction was assessed at the outpatient clinic by six questions regarding aesthetic and functional aspects.
RESULTS: Postoperative photographs demonstrated the height of the nasal dorsum did not decrease over time except two patients whose ADM was grafted into a subperiosteal pocket. Others who underwent supraperiosteal implantation showed acceptable maintenance of dorsal height. No major complication was reported. Overall, patient satisfaction scored 81.02 out of 100.
CONCLUSIONS: Cross-linked human ADM has advantages of both autogenous and alloplastic materials. The surgical results remain stable without complications. Therefore, it is a suitable alternative implant material for dorsal augmentation in rhinoplasty. LEVEL OF EVIDENCE IV: This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266 .

Entities:  

Keywords:  Acellular dermal matrix; Cross-linked acellular dermal matrix; Dorsal augmentation; Rhinoplasty

Mesh:

Year:  2017        PMID: 29124378     DOI: 10.1007/s00266-017-0996-7

Source DB:  PubMed          Journal:  Aesthetic Plast Surg        ISSN: 0364-216X            Impact factor:   2.326


  3 in total

Review 1.  Clinical applications of acellular dermal matrices: A review.

Authors:  Kyla Petrie; Cameron T Cox; Benjamin C Becker; Brendan J MacKay
Journal:  Scars Burn Heal       Date:  2022-01-19

2.  Treatment of Human Immunodeficiency Virus-Associated Facial Lipoatrophy With Hyaluronic Acid Filler Mixed With Micronized Cross-Linked Acellular Dermal Matrix.

Authors:  Jemin Kim; Seung Yong Song; Sang Gyu Lee; Sooyeon Choi; Young In Lee; Jun Yong Choi; Ju Hee Lee
Journal:  J Korean Med Sci       Date:  2022-02-07       Impact factor: 2.153

3.  Comparison of Volume Retention and Biocompatibility of Acellular Dermal Matrix/Hyaluronic Acid Filler to Autologous Fat Grafts in a Mouse Model.

Authors:  Ji Hun Kim; Sun Eung Kim; Yu Jin Kim; Yang Woo Kim; Young Woo Cheon
Journal:  Aesthetic Plast Surg       Date:  2020-03-30       Impact factor: 2.708

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.